[1]
|
Mirsadraee, S., Farzadnia, M., Heidary, F., Rahimi, M., Jabbari Noghabi, H. and Kakhki, S. (2011) A comparative immumohistochemical diagnosis of Hodgkin’s Lymphoma with conventional method.
|
[2]
|
Classical, H., Michael, C., Jame, A., Wyndham, H.W. and Elaine, S.J. (2009) Bethesda handbook of clinical hematology, Lippincott Williams & Wilkins, Philadelphia.
|
[3]
|
Mozaheb, Z. (2012) Epidemiology of lymphoid malignnancy in Asia epidemiology insights. Mashhad University of Medical Science, Mashhad.
|
[4]
|
Mozaheb, Z., Aledavood, A. and Farzad, F. (2011) Distributions of major sub-types of lymphoid malignancies among adults in Mashhad, Iran. Cancer Epidemiology, 35, 26-29. doi:10.1016/j.canep.2010.09.009.
|
[5]
|
Cartwright, R.A. and Watkins, G. (2004) Epidemiology Of hodgkin’s disease: A review. Hematological Oncology, 22, 11-26. doi:10.1002/hon.723
|
[6]
|
Flowers, C.R. and Armitage, J.O. (2010) A Decade of progress in lymphoma: advances and continuing challenges. Clinical Lymphoma Myeloma and Leukemia, 10, 414-423.
doi:10.3816/CLML.2010.n.086.
|
[7]
|
Thomas, R., Re, D., Zander, T., Wolf, J. and Diehl, V. (2002) Epidemiology and etiology of Hodgkin’s lymphoma. Annals of oncology, 13, 147-152.
doi:10.1093/annonc/mdf652.
|
[8]
|
Ries, L.A.G., Miler, B.A., Hankey, B.F. and Harras, A.E.B.K. (1994) SEER cancer statistics review, 1973-1991: Tables and graphs. National Institutes of Health, National Cancer Institute, Bethesda.
|
[9]
|
Swerdlow, A.J. (2003) Epidemiology of hodgkin’s disease and non-Hodgkin’s lymphoma. European Journal of Nuclear Medicine and Molecular Imaging, 30, S3-S12.
doi:10.1007/s00259-003-1154-9
|
[10]
|
Pareen, S., Alison, M., Neha, M. and Christopher, R. (2011) Incidence patterns and outcomes for hodgkin lymphoma patients in the United States. Advances in Hematology, 2011, 725219.
|
[11]
|
Caporaso, N.E., Goldin, L.R., Anderson, W.F. and Landgren, O. (2009) Current insight on trends, causes, and mechanisms of Hodgkin’s lymphoma. The Cancer Journal, 15, 117-123. doi:10.1097/PPO.0b013e3181a39585.
|
[12]
|
Aozasa, K., Ueda, T., Tamai, M. and Tsujimura T. (1986) Hodgkin’s disease in Osaka, Japan (1964-1985). European Journal of Cancer and Clinical Oncology, 22, 11171119. doi:10.1016/0277-5379(86)90016-7
|
[13]
|
Glaser, S.L. and Hsu, J.L. (2002) Hodgkin’s disease in Asians: Incidence patterns and risk factors in population- based data. Leukemia Research, 26, 261-269.
doi:10.1016/S0145-2126(01)00126-6.
|
[14]
|
Correa, P. and O’Conor, G.T. (1971) Epidemiologic patterns of Hodgkin’s disease. International Journal of Cancer, 8, 192-201. doi:10.1002/ijc.2910080203.
|
[15]
|
Spitz, M., Sider, J., Johnson, C., Butler, J., Pollack, E. and Newell, G. (1986) Ethnic patterns of Hodgkin’s disease incidence among children and adolescents in the United States, 1973-1982. Journal of the National Cancer Institute, 76, 235-239.
|
[16]
|
Glaser, S.L. and Jarrett, R.F. (1996) The epidemiology of Hodgkin’s disease. Baillière’s Clinical Haematology, 9, 401-416. doi:10.1016/S0950-3536(96)80018-7
|
[17]
|
Thomas, R.K., Re, D., Zander, T., Wolf, J. and Diehl, V. (2002) Epidemiology and etiology of Hodgkin’s lymphoma. Annals of Oncology, 13, 147-152.
doi:10.1093/annonc/mdf652
|
[18]
|
Wolf, J. and Diehl, V. (1994) Is Hodgkin’s disease an infectious disease? Annals of Oncology, 5, S105-S111.
doi:10.1093/annonc/5.suppl_1.S105.
|
[19]
|
Swerdlow, A.J. (2003) Epidemiology of Hodgkin’s disease and non-Hodgkin’s lymphoma. European Journal of Nuclear Medicine and Molecular Imaging, 30, S3-S12.
doi:10.1007/s00259-003-1154-9.
|
[20]
|
Mueller, N., Evans, A., Harris, N.L., Comstock, G.W., Jellum, E., Magnus, K., et al., (1989) Hodgkin’s disease and Epstein-Barr virus. New England Journal of Medicine, 320, 689-695. doi:10.1056/NEJM198903163201103.
|
[21]
|
Ambinder, R.F. (2007) Epstein-Barr virus and Hodgkin Lymphoma. Hematology, 2007, 204-209.
doi:10.1182/asheducation-2007.1.204
|
[22]
|
Hjalgrim, H., Askling J., Rostgaard, K., Hamilton-Dutoit, S., Frisch, M., Zhang, J.-S., et al., (2003) Characteristics of Hodgkin’s Lymphoma after infectious mononucleosis. New England Journal of Medicine, 349, 1324-1332.
doi:10.1056/NEJMoa023141.
|
[23]
|
Sauce, D., Larsen, M., Leese, A., Millar, D., Khan, N., Hislop, A., et al., (2007) IL 7R versus CCR7 and CD45 as markers of virus specific CD8+ T cell differentiation: Contrasting pictures in blood and tonsillar lymphoid tissue. Journal of Infectious Diseases, 195, 268-278.
doi:10.1086/510248.
|
[24]
|
Landgren, O. and Caporaso, N.E. (2007) New aspects in descriptive, etiologic, and molecular epidemiology of Hodgkin’s Lymphoma. Hematology/Oncology Clinics of North America, 21, 825-840.
doi:10.1016/j.hoc.2007.07.001.
|
[25]
|
Hjalgrim, H., Ekström Smedby, K., Rostgaard, K., Molin, D., Hamilton-Dutoit, S., Chang, E.T., et al., (2007) Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma. Cancer research, 67, 2382.
doi:10.1158/0008-5472.CAN-06-3566.
|
[26]
|
Glaser, S.L., Lin, R.J., Stewart, S.L., Ambinder, R.F., Jarrett, R.F., Brousset, P., et al., (1997) Epstein Barr virus associated Hodgkin’s disease: Epidemiologic characteristics in international data. International Journal of Cancer, 70, 375-382.
doi:10.1002/(SICI)1097-0215(19970207)70:4<375::AID-IJC1>3.0.CO;2-T.
|
[27]
|
Zarate-Osorno, A., Roman, L.N., Kingma, D.W., Meneses-Garcia, A. and Jaffe, E.S. (1995) Hodgkin’s disease in Mexico. Prevalence of Epstein Barr virus sequences and correlations with histologic subtype. Cancer, 75, 13601366.
doi:10.1002/1097-0142(19950315)75:6<1360::AID-CNCR2820750619>3.0.CO;2-U.
|
[28]
|
Brousset, P., Chittal, S., Schlaifer, D., Icart, J., Payen, C., Rigal-Huguet, F., et al., (1991) Detection of Epstein-Barr virus messenger RNA in Reed-Sternberg cells of Hodgkin’s disease by in situ hybridization with biotinylated probes on specially processed modified acetone methyl benzoate xylene (ModAMeX) sections [see comments]. Blood, 77, 1781.
|
[29]
|
Wilson, K., Freeland, J., Gallagher, A., Cosby, S., Earle, J., Alexander, F., et al. (2007) Measles virus and classical Hodgkin lymphoma: No evidence for a direct association. International Journal of Cancer, 121, 442-447.
doi:10.1002/ijc.22629.
|
[30]
|
Mozaheb, Z., Aledavood, A. and Farzad, F. (2012) Diet and non-Hodgkin’s lymphoma risk. The Pan African Medical Journal, 12.
|
[31]
|
Glaser, S.L., Lin, R.J., Stewart, S.L., Ambinder, R.F., Jarrett, R.F., Brousset, P., et al. (1997) Epstein-Barr virus- associated Hodgkin’s disease: Epidemiologic characteristics in international data. International Journal of Cancer, 70, 375-382.
doi:10.1002/(SICI)1097-0215(19970207)70:4<375::AID-IJC1>3.0.CO;2-T.
|
[32]
|
Hjalgrim, H., Ekström Smedby, K., Rostgaard, K., Molin, D., Hamilton-Dutoit, S., Chang, E.T., et al. (2007) Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma. Cancer Research, 67, 2382-2328. doi:10.1158/0008-5472.CAN-06-3566.
|
[33]
|
Flavell, K.J., Biddulph, J.P., Powell, J.E., Parkes, S.E., Redfern, D., Weinreb, M., et al. (2001) South Asian ethnicity and material deprivation increase the risk of Epstein-Barr virus infection in childhood Hodgkin’s disease. British Journal of Cancer, 85, 350-356.
doi:10.1054/bjoc.2001.1872
|
[34]
|
Keegan, T.H.M., Glaser, S.L., Clarke, C.A., Gulley, M.L., Craig, F.E., DiGiuseppe, J.A., et al. (2005) Epstein-Barr virus as a marker of survival after Hodgkin’s lymphoma: A population-based study. Journal of Clinical Oncology, 23, 7604-7613. doi:10.1200/JCO.2005.02.6310.
|
[35]
|
Jarrett, R.F., Stark, G.L., White, J., Angus, B., Alexander, F.E., Krajewski, A.S., et al. (2005) Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study. Blood, 106, 2444- 2451. doi:10.1182/blood-2004-09-3759
|
[36]
|
Jarrett, R.F. (2002) Viruses and Hodgkin’s lymphoma. Annals of Oncology, 13, 23-29.
|
[37]
|
Armstrong, A.A., Alexander, F.E., Cartwright, R., Angus, B., Krajewski, A.S., Wright, D.H., et al. (1998) Epstein- Barr virus and Hodgkin’s disease: Further evidence for the three disease hypothesis. Leukemia, 12, 1272-1276.
doi:10.1038/sj.leu.2401097
|
[38]
|
Goedert, J.J., (2000) The epidemiology of acquired immunodeficiency syndrome malignancies. Seminars in Oncology, 27, 390-401.
|
[39]
|
Frisch, M., Biggar, R.J., Engels, E.A. and Goedert, J.J. (2001) Association of cancer with AIDS-related immunosuppression in adults. The Journal of the American Medical Association, 285, 1736-1745.
doi:10.1001/jama.285.13.1736
|
[40]
|
Clarke, C.A. and Glaser, S.L. (2001) Epidemiologic trends in HIV-associated lymphomas. Current Opinion in Oncology, 13, 315-413.
doi:10.1097/00001622-200109000-00007
|
[41]
|
Glaser, S.L., Clarke, C.A., Gulley, M.L., Craig, F.E., DiGiuseppe, J.A., Dorfman, R.F., et al. (2003) Population based patterns of human immunodeficiency virus related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988-1998. Cancer, 98, 300-309.
doi:10.1002/cncr.11459
|
[42]
|
Filipovich, A., Mathur, A., Kamat, D. and Shapiro, R. (1992) Primary immunodeficiencies: Genetic risk factors for lymphoma. Cancer Research, 52, 5465S.
|
[43]
|
Rowlings, P.A., Curtis, R.E., Passweg, J.R., Deeg, H.J., Socié, G., Travis, L.B., et al. (1999) Increased incidence of Hodgkin’s disease after allogeneic bone marrow transplantation. Journal of Clinical Oncology, 17, 3122-3127.
|
[44]
|
Haim, N., Cohen, Y. and Robinson, E. (1982) Malignant lymphoma in first degree blood relatives. Cancer, 49, 2197-2200. doi:10.1002/1097-0142(19820515)49:10<2197::AID-CNCR2820491036>3.0.CO;2-9.
|
[45]
|
Abramson, J., Pridan, H., Sacks, M., Avitzour, M., Peritz, E. (1978) A case-control study of Hodgkin’s disease in Israel. Journal of the National Cancer Institute, 61, 307-314.
|
[46]
|
Goldin, L., McMaster, M., Ter-Minassian, M., Saddlemire, S., Harmsen, B., Lalonde, G., et al. (2005) A genome screen of families at high risk for Hodgkin lymphoma: Evidence for a susceptibility gene on chromosome 4. Journal of Medical Genetics, 42, 595-601.
doi:10.1136/jmg.2004.027433.
|
[47]
|
Easton, D. and Peto, J. (1990) The contribution of inherited predisposition to cancer incidence. Cancer Survivors, 9, 395-416.
|
[48]
|
Oza, A.M., Tonks, S., Lim, J., Fleetwood, M.A., Lister, T.A., Bodmer, J.G., et al. (1994) A clinical and epidemicological study of human leukocyte antigen-DPB alleles in Hodgkin’s disease. Cancer Research, 54, 5101.
|
[49]
|
Lindelöf, B. and Eklund, G. (2001) Analysis of hereditary component of cancer by use of a familial index by site. The Lancet, 358, 1696-1698.
doi:10.1016/S0140-6736(01)06721-6
|
[50]
|
Matricardi, P.M. and Bonini, S. (2000) High microbial turnover rate preventing atopy: A solution to inconsistencies impinging on the Hygiene hypothesis? Clinical & Experimental Allergy, 30, 1506-1510.
doi:10.1046/j.1365-2222.2000.00994.x.
|
[51]
|
Cozen, W., Hamilton, A.S., Zhao, P., Salam, M.T., Deapen, D.M., Nathwan, B.N., et al. (2009) A protective role for early oral exposures in the etiology of young adult Hodgkin lymphoma. Blood, 114, 4014-4020.
doi:10.1182/blood-2009-03-209601.
|